The government says funding for COVID vaccines and antivirals are up for consideration next year. With so much unknown about the long-term impact of COVID, will cost become a barrier to access?
Articles on COVID-19 vaccine boosters
Displaying all articles
Many questions remain about next steps for US vaccine policy. But the FDA advisory panel’s hearty endorsement of a single-composition COVID-19 vaccine represents a pivotal step.
New Zealand’s proportion of reinfections is now at 17% of new cases. As new variants continue to proliferate, vaccine boosters would protect those most vulnerable and reduce the risk of long COVID.
Early on, public health messaging focused on the need for vaccines to combat COVID-19. But far less attention has been given to the role of boosters in preventing deaths and reducing inequities.
The last Omicron wave affected younger people. But the new BA.5 variant is seeing case numbers in older age groups higher than ever before – just as hospitals are under the most pressure.
A new generation of vaccines and boosters against SARS-CoV-2 may take a page from the anti-influenza playbook, with shots periodically tailored to target the most commonly circulating virus strains.
The COVID-19 vaccines continue to be effective against severe illness leading to hospitalization and death in all age groups, including children ages 5 to 11.
It’s too soon to recommend booster shots for younger children. But we can watch what’s happening in the US, where children as young as 12 are receiving theirs.
Many Australians are yet to have a third COVID vaccine dose, while people overseas are having their fourth shot.
Top contributors
-
Assistant Professor of Sociology, University of Minnesota
-
Professor of Public Health, Te Kunenga ki Pūrehuroa – Massey University
-
Senior Lecturer; MD, Victoria University
-
Research Assistant in the Department of Global Health, Boston University
-
Senior Lecturer, University of Auckland, Waipapa Taumata Rau
-
Professor in Applied Mathematics, University of Canterbury
-
Professor, The Children's Hospital at Westmead Clinical School and Sydney Infectious Diseases Institute, University of Sydney
-
Instructor of Human Immunology, Emory University
-
Associate Professor of Pediatrics, University of Virginia
-
Research Fellow in Global Health, Boston University
-
Distinguished Professor, Professor of Immunology, RMIT University
-
Research scientist, Manaaki Whenua - Landcare Research
-
Postdoctoral Fellow in Epidemiology, University of North Carolina at Chapel Hill
-
Assistant Professor of Global Health, Boston University
-
Vice Chancellors Senior Research Fellow in Immunology, RMIT University